New hope for Crohn's: Long-Term maintenance drug enters final testing
NCT ID NCT07184944
First seen Sep 30, 2025 · Last updated May 19, 2026 · Updated 29 times
Summary
This study tests a new medicine called duvakitug for people with moderate to severe Crohn's disease who have already responded to treatment. The goal is to see if duvakitug can help keep the disease in remission longer than a placebo. About 751 adults will take part, and the study lasts up to 5.5 years, including an open-label extension where everyone gets the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bioresearch Partner-Kendale Lakes-Site Number: 8400053
RECRUITINGMiami, Florida, 33175, United States
-
Clinical Research of Osceola-Site Number: 8400013
RECRUITINGKissimmee, Florida, 34741, United States
-
Cross Creek Medical Clinic-Site Number: 8400057
RECRUITINGFayetteville, North Carolina, 28304, United States
-
GI Alliance - Baton Rouge-Site Number: 8400129
RECRUITINGBaton Rouge, Louisiana, 70809, United States
-
Gastroenterology Associates of Western Michigan-Site Number: 8400060
RECRUITINGWyoming, Wyoming, 49519, United States
-
Gastroenterology Research of San Antonio LLC-Site Number: 8400054
RECRUITINGSan Antonio, Texas, 78229, United States
-
Gateway Gastroenterology-Site Number: 8400097
RECRUITINGSt Louis, Missouri, 63141, United States
-
Investigational Site Number : 1240003
RECRUITINGToronto, M6A 3B4, Canada
-
NMC Research LLC-Site Number: 8400033
RECRUITINGTampa, Florida, 33607, United States
-
NYU Langone Health-Site Number: 8400091
RECRUITINGNew York, New York, 10016, United States
-
New York Gastroenterology Associates-Site Number: 8400009
RECRUITINGNew York, New York, 10075, United States
-
OSU Wexner Medical Center-Site Number: 8400077
RECRUITINGColumbus, Ohio, 43210, United States
-
Ohio Gastroenterology Group Inc.-Site Number: 8400006
RECRUITINGColumbus, Ohio, 43202, United States
-
Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039
RECRUITINGColorado Springs, Colorado, 80907, United States
-
Tyler Research Institute LLC-Site Number: 8400095
RECRUITINGTyler, Texas, 75701, United States
Conditions
Explore the condition pages connected to this study.